Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review)

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The lethal-7 (Let-7) family of microRNAs (miRNAs) controls the process of development and differentiation, but is also related to the occurrence of tumors and a poor prognosis of patients with tumors. Thus, a more comprehensive exploration of its functions will provide further insights into these processes, and may promote the diagnosis and treatment of tumors. Leukemia is a type of progressive malignant disease, and its pathogenesis involves a variety of epigenetic factors. Amongst the several related epigenetic factors, the Let-7 miRNAs are an important family of molecules that play a crucial role in maintaining a variety of critical biological processes, including development, differentiation and proliferation. In the present study, the role of Let-7 as a tumor suppressor gene and oncogene is reviewed, and the complex regulatory functions of several Let-7 family members in different subtypes of leukemia are described. The current body of knowledge thus far indicates that Let-7 is not only a potential diagnostic and prognostic marker of leukemia, but also a potential therapeutic target for the treatment of affected patients, with particular potential when targeted by adjuvant treatments alongside traditional treatment to improve their survival rate.

Cite

CITATION STYLE

APA

CHEN, H., WANG, J., WANG, H., LIANG, J., DONG, J., BAI, H., & JIANG, G. (2022, January 1). Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review). Oncology Letters. Spandidos Publications. https://doi.org/10.3892/ol.2021.13119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free